Stock Taper
QGEN
QIAGEN N.V.
NYSE
$43.11
▼ DOWN 1.44% (-0.63)

KEY STATISTICS

Market Cap$8.89 B
52w High$57.82
52w Low$32.53
Dividend Yield6.76%
FrequencySemi-Annual
P/E17.81
Volume1.38M
Shares Out.206.25M

COMPANY

LEADERSHIP

Thierry L. Bernard
CHIEF EXECUTIVE
Thierry L. Bernard

ABOUT

SECTOR
Healthcare
WENT PUBLIC
June 28, 1996
METHOD OF GOING PUBLIC
Dual Listing
FULL TIME EMPLOYEES
5,500

PRICE TARGET

Target High$48.00
Target Low$38.60
Target Median$42.50
Target Consensus$42.51

UPCOMING EARNINGS

DateNov 3, 2026
DayTuesday
Rev. Est.$535.87M
NOV
3
TUE

SPLIT RECORD

DATETYPERATIO
2026-01-08Reverse19:20
2025-01-29Reverse35:36
2024-01-30Reverse97:100
2017-01-25Reverse481:500
2000-07-14Forward4:1
1999-07-16Forward2:1

PRICE

$43.11 ▼ DOWN 1.44% (−$0.63)
OVERLAYS
$43.00$43.25$43.50$43.759:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM43.11

About Qiagen N.V.

https://www.qiagen.com ↗

QIAGEN N.V. provides sample-to-insight molecular testing solutions, including consumables, instruments, assays, and bioinformatics for diagnostics, research, and pharma worldwide.

INDUSTRY

Medical - Diagnostics & Research

A PRODUCT QIAGEN N.V. IS KNOWN FOR

QIAcuity Digital PCR System
QIAcuity Digital PCR System

The QIAcuity is an automated digital PCR system by Qiagen that offers rapid, precise nucleic acid quantification in under two hours, streamlining mutation detection, gene expression, and copy number analysis.

Revenue by Products

IconPRODUCTFY2022FY2023FY2024FY2025
Consumables and Related$1.88B
Diagnostic Solutions$660.88M $697.63M $748.89M $803.08M
Sample Technologies$796.93M $662.99M $642.03M $661.26M
PCR Nucleic Acid Amplification$390.8M $300.2M $300.47M $308.99M
Genomics NGS$224.8M $238.91M $233.61M $241.78M
Instruments$213.57M
Product and Service Other$68.11M $65.58M $53.22M $74.89M

Revenue by Geography

MapREGIONFY2022FY2023FY2024FY2025
Total Americas$997.75M $1.02B $1.03B $1.09B
UNITED STATES$998.45M
EMEA$733.47M $624.57M $648.49M $712.76M
Asia Pacific and Rest of World$410.29M $320.68M $298.15M $290.73M
Other Americas$88.06M

RATINGS SNAPSHOT

Overall rating: A-

DCFROEROAD/EP/EP/B
Discounted Cash Flow5
Return On Equity4
Return On Assets4
Debt To Equity2
Price To Earnings2
Price To Book3
Overall Score4

TRADES BY CONGRESS

HOUSE TRADES
Ro Khanna
Ro Khanna
Sale
2022-04-13
Peter Welch
Peter Welch
Sale (Full)
2020-03-24
Alan S. Lowenthal
Alan S. Lowenthal
Sale (Full)
2019-10-08
Donna Shalala
Donna Shalala
Sale (Partial)
2019-01-23

MOST RECENT ANALYST GRADES

GRADE SUMMARY
OVERWEIGHT 2
HOLD 2
NEUTRAL 1
EQUAL WEIGHT 1
OUTPERFORM 1
BUY 1
8 GRADES IN THE LAST 12 MONTHS

SECTORS PEERS

PEERPRICE
RVTY$128.80COMPARE
CRL$291.50COMPARE
EXEL$54.45COMPARE
BAX$26.13COMPARE
ICLR$170.02COMPARE
BMRN$64.67COMPARE
TECH$72.35COMPARE
ALGN$157.58COMPARE